The STEP 1 trial (Wilding et al., N Engl J Med, 2021) documented nausea in 44.2% of participants at the 2.4 mg dose versus 17.4% on placebo
Diarrhea, vomiting and other side effects of Zepbound and Mounjaro can cause severe dehydration, leading to acute kidney injury (AKI)
Supports neurotransmitter synthesis, is anti-inflammatory, and is especially useful for mood disorders, depression, dementia, PMS, skin disorders, and neuropathy
Immediate medical review is advisable if: Anxiety symptoms are severe, persistent, or significantly impair daily activities, work, or relationships Symptoms are accompanied by thoughts of self-harm or suicide Physical symptoms such as chest pain, severe palpitations, or breathing difficulties occur Suspected hypoglycaemia episodes are frequent or severe Gastrointestinal side effects are intolerable or lead to dehydration New or worsening depression accompanies anxiety symptoms For severe symptoms or imminent risk, call 999 or attend A&E
Verify your dose volume is still correct